Ikarian Capital, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ikarian Capital, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$272,093
-99.3%
32,547
-98.0%
0.03%
-99.5%
Q2 2023$41,040,648
+195331.7%
1,652,200
+71985.5%
6.54%
+217766.7%
Q1 2022$21,000
-99.4%
2,292
-98.9%
0.00%
-99.5%
Q4 2021$3,787,000
+15.4%
199,339
+102.2%
0.56%
+144.2%
Q3 2021$3,282,000
-15.4%
98,600
-1.4%
0.23%
-26.2%
Q2 2021$3,878,000
-19.5%
100,0000.0%0.31%
+93.2%
Q1 2021$4,820,000
-7.3%
100,0000.0%0.16%
-29.3%
Q4 2020$5,202,000
+48.2%
100,000
-68.4%
0.23%
-59.8%
Q4 2019$3,510,000316,2000.57%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RA Capital Management 8,198,337$33,613,0001.96%
GREAT POINT PARTNERS LLC 3,000,000$12,300,0001.56%
BRIDGER MANAGEMENT, LLC 3,791,531$15,545,0001.30%
Avoro Capital Advisors LLC 4,750,000$19,475,0001.16%
Opaleye Management Inc. 550,000$2,255,0000.84%
CREDIT AGRICOLE S A 1,307,428$5,360,0000.30%
Eversept Partners, LP 65,000$266,5000.14%
HIGHLAND CAPITAL MANAGEMENT LP 453,360$1,859,0000.14%
683 Capital Management, LLC 500,000$2,050,0000.12%
Artal Group S.A. 400,000$1,640,0000.06%
View complete list of TG THERAPEUTICS INC shareholders